These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2964844

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The minimum effective dose of glucagon in upper gastrointestinal radiography.
    Maglinte DD, Caudill LD, Krol KL, Chernish SM, Brown DL.
    Gastrointest Radiol; 1982; 7(2):119-22. PubMed ID: 7084592
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of glucagon on the double contrast examination of the stomach and duodenum.
    Mäkelä P, Rossi I, Kormano M.
    Rofo; 1978 Oct; 129(4):418-20. PubMed ID: 152234
    [Abstract] [Full Text] [Related]

  • 9. Effect of glucagon, glicentin, glucagon-like peptide-1 and -2 on interdigestive gastroduodenal motility in dogs with a vagally denervated gastric pouch.
    Shibata C, Naito H, Jin XL, Ueno T, Funayama Y, Fukushima K, Hashimoto A, Matsuno S, Sasaki I.
    Scand J Gastroenterol; 2001 Oct; 36(10):1049-55. PubMed ID: 11589377
    [Abstract] [Full Text] [Related]

  • 10. Gastrointestinal response to minute doses of glucagon.
    Miller RE, Chernish SM, Greenman GF, Maglinte DD, Rosenak BD, Brunelle RL.
    Radiology; 1982 May; 143(2):317-20. PubMed ID: 7071331
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of pectin on gastric emptying and gastroduodenal motility in normal subjects.
    Sandhu KS, el Samahi MM, Mena I, Dooley CP, Valenzuela JE.
    Gastroenterology; 1987 Feb; 92(2):486-92. PubMed ID: 3539692
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of glucagon and glucagon-(1-21)-peptide on antroduodenal motility in healthy volunteers.
    Gregersen H, Rittig S, Kraglund K, Phillips S.
    Scand J Gastroenterol Suppl; 1988 Feb; 152():42-7. PubMed ID: 3254614
    [Abstract] [Full Text] [Related]

  • 18. Double-blind radiographic study of dose response to intravenous glucagon for hypotonic duodenography.
    Miller RE, Chernish SM, Brunelle RL, Rosenak BD.
    Radiology; 1978 Apr; 127(1):55-9. PubMed ID: 345342
    [Abstract] [Full Text] [Related]

  • 19. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
    Camilleri M, Vazquez-Roque M, Iturrino J, Boldingh A, Burton D, McKinzie S, Wong BS, Rao AS, Kenny E, Månsson M, Zinsmeister AR.
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.